KTTA
7:00 AM
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference
Presentation / Abstract • Phase 1Poster presentation Thu, Nov 12, 2026, 7:00 AM CETpasithea.com